Vitamin E and cardiovascular disease: Observational studies

Annals of the New York Academy of Sciences

Volumn 1031, Issue , 2004, Pages 280-291

  Gaziano, J Michael ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Antioxidant; Cardiovascular disease; Vitamin E

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; BETA CAROTENE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; OMEGA 3 FATTY ACID; PLACEBO; RAMIPRIL; SELENIUM;

ATHEROSCLEROSIS; CANCER PREVENTION; CARDIOVASCULAR DISEASE; CASE CONTROL STUDY; CLINICAL TRIAL; COHORT ANALYSIS; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET; EXERCISE; FOLLOW UP; FRUIT; HEART INFARCTION; HUMAN; LUNG CANCER; MORTALITY; OXIDATIVE STRESS; PRIMARY PREVENTION; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; SECONDARY PREVENTION; STROKE; SYSTEMATIC REVIEW; TISSUE LEVEL; VEGETABLE; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION;

EID: 14944367546     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1331.028     Document Type: Conference Paper

References (46)

1. STEINBERG, D. et al. 1989. Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity. N. Engl. J. Med. 320: 915-924.
2. HESSLER, J.R. et al. 1983. Lipoprotein oxidation and lipoprotein-induced cytotoxicity. Arteriosclerosis 3: 215-222.
3. YAGI, K. 1984. Increased serum lipid peroxides initiate atherogenesis. Bioassays 1: 58-60.
4. GERRITY, R.G. 1981. The role of the monocyte in atherogenesis. I. Transition of blood-borne monocytes into foam cells in fatty lesions. Am. J. Pathol. 103: 181-190.
5. QUINN, M.T., S. PARTHASARATHY & D. STEINBERG. 1985. Endothelial cell-derived chemotactic activity for mouse peritoneal macrophages and the effects of modified forms of low-density lipoprotein. Proc. Natl. Acad. Sci. USA 82: 5949-5953.
6. SCHAFFNER, T. et al. 1980. Arterial foam cells with distinctive immunomorphologic and histochemical features of macrophages. Am. J. Pathol. 100: 57-80.
7. GOLDSTEIN, J.L. et al. 1979. Binding site on macrophages that mediates uptake and degradation of acetylated low-density lipoprotein, producing massive cholesterol deposition. Proc. Natl. Acad. Sci. USA 76: 333-337.
8. FOGELMAN, A.M. et al. 1980. Malondialdehyde alteration of low-density lipoproteins leads to cholesteryl ester accumulation in human monocyte-macrophages. Proc. Natl. Acad. Sci. USA 77: 2214-2218.
9. SALONEN, J.T. et al. 1992. Autoantibody against oxidised LDL and progression of carotid atherosclerosis. Lancet 339: 883-887.
10. BECKMAN, J.S. et al. 1990. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and Superoxide. Proc. Natl. Acad. Sci. USA 87: 1620-1624.
11. MARCUS, A.J. et al. 1977. Superoxide production and reducing activity in human platelets. J. Clin. Invest. 59: 149-158.
12. 2-: implications for the action of endothelium-derived relaxing factor (EDRF). Free Radic. Res. Commun. 10: 221-226.
13. WOJCICKI, J. et al. 1991. Effect of selenium and vitamin E on the development of experimental atherosclerosis in rabbits. Atherosclerosis 87: 9-16.
14. WILLIAMS, R.J. et al. 1992. Dietary vitamin E and the attenuation of early lesion development in modified Watanabe rabbits. Atherosclerosis 94: 153-159.
15. KEANEY, J.F., JR. et al. 1994. Low-dose alpha-tocopherol improves and high-dose alpha-tocopherol worsens endothelial vasodilator function in cholesterol-fed rabbits. J. Clin. Invest. 93: 844-851.
16. SMITH, T.L. & P.A. KUMMEROW. 1989. Effect of dietary vitamin E on plasma lipids and atherogenesis in restricted ovulator chickens. Atherosclerosis 75: 105-109.
17. VERLANGIERI, A.J. & M.J. BUSH. 1992. Effects of d-alpha-tocopherol supplementation on experimentally induced primate atherosclerosis. J. Am. Coll. Nutr. 11: 131-138.
18. GEY, K.F. & P. PUSKA. 1989. Plasma vitamins E and A inversely correlated to mortality from ischemic heart disease in cross-cultural epidemiology. Ann. N.Y. Acad. Sci. 570: 268-282.
19. RIEMERSMA, R.A. et al. 1990. Plasma antioxidants and coronary heart disease: vitamins C and E, and selenium. Eur. J. Clin. Nutr. 44: 143-150.
20. RIEMERSMA, R.A. et al. 1989. Low plasma vitamins E and C: increased risk of angina in Scottish men. Ann. N.Y. Acad. Sci. 570: 291-295.
21. RIEMERSMA, R.A. et al. 1991. Risk of angina pectoris and plasma concentrations of vitamins A, C, and E and carotene. Lancet 337: 1-5.
22. KARDINAAL, A.F. et al. 1993. Antioxidants in adipose tissue and risk of myocardial infarction: the EURAMIC Study. Lancet 342: 1379-1384.
23. STAMPFER, M.J. et al. 1993. Vitamin E consumption and the risk of coronary disease in women. N. Engl. J. Med. 328: 1444-1449.
24. RIMM, E.B. et al. 1993. Vitamin E consumption and the risk of coronary heart disease in men. N. Engl. J. Med. 328: 1450-1456.
25. KUSHI, L.H. et al. 1996. Intake of vitamins A, C, and E and postmenopausal breast cancer: the Iowa Women's Health Study. Am. J. Epidemiol. 144: 165-174.
26. KNEKT, P. et al. 1994. Antioxidant vitamin intake and coronary mortality in a longitudinal population study. Am. J. Epidemiol. 139: 1180-1189.
27. MEYER, F., I. BAIRATI & G.R. DAGENAIS. 1996. Lower ischemic heart disease incidence and mortality among vitamin supplement users. Can. J. Cardiol. 12: 930-934.
28. LOSONCZY, K.G., T.B. HARRIS & R.J. HAVLIK. 1996. Vitamin E and vitamin C supplement use and risk of all-cause and coronary heart disease mortality in older persons: the Established Populations for Epidemiologic Studies of the Elderly. Am. J. Clin. Nutr. 64: 190-196.
29. KLIPSTEIN-GROBUSCH, K. et al. 1999. Dietary antioxidants and risk of myocardial infarction in the elderly: the Rotterdam Study. Am. J. Clin. Nutr. 69: 261-266.
30. HERCBERG, S. et al. 1998. A primary prevention trial using nutritional doses of antioxidant vitamins and minerals in cardiovascular diseases and cancers in a general population: the SU.VI.MAX study-design, methods, and participant characteristics. Supplementation en Vitamines et Mineraux AntioXydants. Control Clin. Trials 19: 336-351.
31. The Alpha-Tocopherol Beta Carotene Cancer Prevention Study Group. 1994. The effect of vitamin E and beta-carotene on the incidence of lung cancer and other cancers in male smokers: the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study Group. N. Engl. J. Med. 330: 1029-1035.
32. RAPOLA, J.M. et al. 1996. Effect of vitamin E and beta-carotene on the incidence of angina pectoris: a randomized, double-blind, controlled trial. J. Am. Med. Assoc. 275: 693-698.
33. VIRTAMO, J. et al. 2003. Incidence of cancer and mortality following alpha-tocopherol and beta-carotene supplementation: a postintervention follow-up. J. Am. Med. Assoc. 290: 476-485.
34. DE GAETANO, G. 2001. Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice. Collaborative Group of the Primary Prevention Project. Lancet 357: 89-95.
35. HODIS, H.N. et al. 2002. Alpha-tocopherol supplementation in healthy individuals reduces low-density lipoprotein oxidation but not atherosclerosis: the Vitamin E Atherosclerosis Prevention Study (VEAPS). Circulation 106: 1453-1459.
36. STEPHENS, N.G. et al. 1996. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 347: 781-786.
37. The GISSI-Prevenzione Investigators. 1999. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. Lancet 354: 447-455.
38. YUSUF, S. et al. 2000. Vitamin E supplementation and cardiovascular events in high-risk patients: the Heart Outcomes Prevention Evaluation Study Investigators. N. Engl. J. Med. 342: 154-160.
39. BURING, J.E. & C.H. HENNEKENS (for the Women's Health Study Research Group). 1992. The Women's Health Study: summary of the study design. J. Myocard. Isch. 4: 27-29.
40. CHRISTEN, W.G., J.M. GAZIANO & C.H. HENNEKENS. 2000. Design of Physicians' Health Study II: a randomized trial of beta-carotene, vitamins E and C, and multivitamins, in prevention of cancer, cardiovascular disease, and eye disease, and review of results of completed trials. Ann. Epidemiol. 10: 125-134.
41. MANSON, J.E. et al. 1995. A secondary prevention trial of antioxidant vitamins and cardiovascular disease in women: rationale, design, and methods. The WACS Research Group. Ann. Epidemiol. 5: 261-269.
42. KLEIN, E.A. et al. 2001. SELECT: the next prostate cancer prevention trial. Selenum and Vitamin E Cancer Prevention Trial. J. Urol. 166: 1311-1315.
43. JIANG, Q. et al. 2001. Gamma-tocopherol, the major form of vitamin E in the U.S. diet, deserves more attention. Am. J. Clin. Nutr. 74: 714-722.
44. LIU, M. et al. 2003. Mixed tocopherols inhibit platelet aggregation in humans: potential mechanisms. Am. J. Clin. Nutr. 77: 700-706.
45. DEVARAJ, S. & M.G. TRABER. 2003. Gamma-tocopherol, the new vitamin E? Am. J. Clin. Nutr. 77: 530-531.
46. 2003. Summaries for patients taking vitamin supplements to prevent cardiovascular disease and cancer: recommendations from the U.S. Preventive Services Task Force. Ann. Intern. Med. 139: 1-76.